Cargando…
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
Dendritic cell (DC) vaccine was among the first FDA-approved cancer immunotherapies, but has been limited by the modest cytotoxic T lymphocyte (CTL) response and therapeutic efficacy. Here we report a facile metabolic labeling approach that enables targeted modulation of adoptively transferred DCs f...
Autores principales: | Han, Joonsu, Bhatta, Rimsha, Liu, Yusheng, Bo, Yang, Elosegui-Artola, Alberto, Wang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439884/ https://www.ncbi.nlm.nih.gov/pubmed/37598185 http://dx.doi.org/10.1038/s41467-023-40886-7 |
Ejemplares similares
-
In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy
por: Han, Joonsu, et al.
Publicado: (2022) -
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
por: Liu, Yusheng, et al.
Publicado: (2022) -
Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine
por: Aipire, Adila, et al.
Publicado: (2017) -
Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth()
por: El Ghazal, Roland, et al.
Publicado: (2016) -
Role of dendritic cells in the regulation of antitumor immunity
por: Wathelet, Nathalie, et al.
Publicado: (2013)